SK
Skinvisible, Inc.
SKVI · OTC
$0.20 +0.00% (+$0.00)
1M +141.11%
Market Cap $1.09M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.26
29.4% upside
Current Price
$0.2
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SKVI is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/S 54.31x
P/E N/A
EV/FFO N/A
Growth
0 /100
Declining Rev. growth 58.47%
EPS growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Gross margin 1.20%
FCF margin 192,050,000.00%
Net margin 5,156.59%
Quality
32 /100
Poor ROIC 9.07%
Asset turnover 0.16x
ROA 836.20%
Debt
0 /100
High Current ratio 0.01x
Int. coverage -0.80x
Debt/Equity N/A
Stability
5 /100
Unstable Beta 1.73x
Profitable years 0
Rev. volatility 53.60%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SKVI
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Terry H. Howlett
Employees
2
Headquarters
Las Vegas